Zhaochao Liang
Overview
Explore the profile of Zhaochao Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He Q, Shu J, Liang Z, Li M, Li S, Liu T, et al.
Zoonoses Public Health
. 2025 Jan;
PMID: 39777991
Introduction: Laboratory animals are widely used in biomedical research. Surveillance of naturally occurring virus in laboratory animals is important to fully understand the results of animal experiment, control laboratory-acquired infections...
2.
Zhang F, Yang Z, Dai C, He Q, Liang Z, Liu T, et al.
J Med Virol
. 2022 Oct;
95(1):e28193.
PMID: 36202778
An important goal of the Hepatitis E virus (HEV) vaccine is to prevent adverse pregnancy outcomes caused by different HEV genotypes during pregnancy, but studies directly evaluating maternal vaccination for...
3.
Liang Z, Wang L, Wang L
Chin Med J (Engl)
. 2022 Jul;
135(10):1231-1233.
PMID: 35787530
No abstract available.
4.
He Q, Zhang F, Shu J, Li S, Liang Z, Du M, et al.
Hepatology
. 2022 Mar;
76(3):788-802.
PMID: 35278241
Background And Aims: HEV infection can lead to chronicity and rapid progression to liver fibrosis and cirrhosis in immunocompromised organ transplant recipients. Robust animal models are urgently needed to study...
5.
Liang Z, Shu J, He Q, Zhang F, Dai L, Wang L, et al.
Antiviral Res
. 2022 Mar;
199:105274.
PMID: 35247472
Hepatitis E virus (HEV) is an important cause of viral hepatitis worldwide and there is currently no FDA-approved anti-HEV drug. The commonly used drug ribavirin (RBV) could not achieve viral...
6.
Li Y, Yu P, Kessler A, Shu J, Liu X, Liang Z, et al.
Hepatology
. 2021 Aug;
75(1):196-212.
PMID: 34392558
Background And Aims: HEV infection is the most common cause of liver inflammation, but the pathogenic mechanisms remain largely unclear. We aim to explore whether HEV infection activates inflammasomes, crosstalk...
7.
Li S, He Q, Yan L, Li M, Liang Z, Shu J, et al.
Emerg Microbes Infect
. 2020 Nov;
9(1):2697-2705.
PMID: 33251979
The pathogenicity of each hepatitis E virus (HEV) genotypes/subtypes may be different. This study aimed to investigate the infectivity and pathogenicity of different HEV genotypes/subtypes from different mammalian sources especially...
8.
Li S, Li M, He Q, Liang Z, Shu J, Wang L, et al.
J Viral Hepat
. 2020 Aug;
28(1):186-195.
PMID: 32853437
Rabbit hepatitis E virus (HEV3-ra) is widely distributed in rabbits worldwide and several recent reports found that HEV3-ra can infect humans. Therefore, people exposed to rabbits are at high risk...
9.
Li M, Li S, He Q, Liang Z, Wang L, Wang Q, et al.
Emerg Microbes Infect
. 2019 Jul;
8(1):1066-1075.
PMID: 31339458
Hepatitis E virus (HEV) can lead to high mortality during pregnancy. This study was to investigate the adverse pregnancy outcomes caused by different HEV genotypes and their prevention by HEV...
10.
Wang L, Zhang Z, Shu J, Zhang H, Yang Y, Liang Z, et al.
Gut
. 2019 Jun;
69(7):1363-1364.
PMID: 31217236
No abstract available.